RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction

Clinical trial NCT07166380 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07166380
Sponsor: Neurodawn Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Transcranial Bone Marrow Injection RK-4 Acute Large Hemispheric Infarction Acute Ischemic Stroke

Start date: 2025-09-20
Primary completion: 2026-02-20
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.